Home > Cashflow Statement > AARTI DRUGS

AARTI DRUGS
Cash Flow from Financing Activities

    Back to Cashflow Statement
COMMUNITY POLL
for AARTI DRUGS
Please provide your vote to see the results

AARTI DRUGS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Financing Activities ₹-136 Cr₹17 Cr₹92 Cr₹-81 Cr₹-215 Cr

What is the latest Cash Flow from Financing Activities ratio of AARTI DRUGS ?

The latest Cash Flow from Financing Activities ratio of AARTI DRUGS is ₹-136 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Financing Activities
Mar2024₹-136 Cr
Mar2023₹17 Cr
Mar2022₹92 Cr
Mar2021₹-81 Cr
Mar2020₹-215 Cr

How is Cash Flow from Financing Activities of AARTI DRUGS Trending?

Years Cash Flow from Financing Activities % Change
Mar2024 ₹-136 Cr
Negative
Mar2023 ₹17 Cr
-82.02
Mar2022 ₹92 Cr
Positive
Mar2021 ₹-81 Cr
Negative
Mar2020 ₹-215 Cr -

Compare Cash Flow from Financing Activities of peers of AARTI DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI DRUGS ₹3,184.1 Cr -3.7% 1.9% -29.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹439,126.0 Cr 0.9% 2.2% 23.9% Stock Analytics
DIVIS LABORATORIES ₹161,568.0 Cr 3.3% 4.7% 58% Stock Analytics
CIPLA ₹125,156.0 Cr 0.5% 2% 11.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,176.0 Cr -0.4% 2.8% 24.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,716.1 Cr -0.8% -0.4% 0.8% Stock Analytics


AARTI DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI DRUGS

-3.7%

1.9%

-29.9%

SENSEX

0.2%

2.9%

8.7%


You may also like the below Video Courses